Results 191 to 200 of about 19,867 (255)

Next-Generation Oncolytic Viruses to Overcome Resistance to Anti-PD-1 Therapy in Melanoma. [PDF]

J Clin Oncol
McArthur GA.
europepmc   +1 more source

Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review). [PDF]

Int J Oncol
Bi S, Shan T, Tang Y, Wang Q.
europepmc   +1 more source

Hydrogel Micro/Nanostructures for the Delivery of Oncolytic Viruses: Overcoming Limitations and Improving Efficacy. [PDF]

Adv Pharm Bull
Hsu CY, Jasim SA, Rizaev JA, Basunduwah TS, Abbot V, Chahar M, Asiri M, Ali AF, Yumashev A, Zwamel AH.   +9 more
europepmc   +1 more source

Novel anticancer combination therapies using replication-selective oncolytic adenoviruses and chemotherapeutics

, 2011
Hammarén Busch, Kristina
core  

Going viral: targeting glioblastoma using oncolytic viruses. [PDF]

Immunother Adv
Coates K, Nibbs RJ, Fraser AR.
europepmc   +1 more source

Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential. [PDF]

Front Microbiol
Gupta A, Chavan SR, Gadepalli R, Pareek P.   +3 more
europepmc   +1 more source

A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. [PDF]

Cancer Cell Int
Sui B, Jin X, Zheng X.
europepmc   +1 more source

Harnessing oncolytic viruses to overcome immunosuppression in breast cancer: from mechanisms to clinical translation. [PDF]

Front Immunol
Xianshu K, Zhonghua L, Junyu D, Qing P, Li Z, Feiyue Z, Xuqing S.   +6 more
europepmc   +1 more source

Combination therapy with oncolytic viruses for lung cancer treatment. [PDF]

Front Oncol
Sun L, Zhao Q, Miao L.
europepmc   +1 more source